Thor Medical ASA (OSL:TRMED)
kr 1.018 0.014 (1.39%) Market Cap: 239.09 Mil Enterprise Value: 210.39 Mil PE Ratio: 0 PB Ratio: 0.93 GF Score: 39/100

Q1 2019 Nordic Nanovector ASA Earnings Call Transcript

May 23, 2019 / 06:30AM GMT
Release Date Price: kr41.89 (-4.89%)
Eduardo Bravo
Nordic Nanovector ASA - CEO

Okay. Welcome. Good morning, everyone. Welcome to the first quarter 2019 report for the highlights and the financial summary of the first quarter of this year. I think that most of you know me, and it's great to see faces that I've -- I can almost recognize all of you from previous meetings. I'm Eduardo Bravo. I'm the CEO of Nordic Nanovector. And aside -- you probably have seen as well, I have with me out of the people from the leadership team, which will, of course, be more than happy at the end of the call to take your questions.

As there's no very difficult technical information to be presented, I'm going to, for the first time, take you myself through the presentation. But then Lisa, Marco and Tone will join me in the stand as if you do any difficult questions, then I can pass them to them, and there you will have the best possible answer.

You also know me, so I always start here. I'm going to be making for sure some forward-looking statements. So before you take any decisions, please read the documentation that we have on the web.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot